June 18, 2021
Business News

Crescita Reports First Quarter 2021 Results


LAVAL, Quebec–()–Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company, today reported its financial results for the first quarter ended March 31, 2021 (“Q1-F2021”). All amounts presented are in thousands of Canadian dollars (“CAD”) unless otherwise noted.

Financial Highlights

Q1-F2021 vs. Q1-F2020

  • Revenue was $3,265 compared to $3,815, a decrease of $550;
  • Gross profit was $2,116 compared to $2,464, a decrease of $348;
  • Operating expenses were $2,413 compared to $2,825, a decrease of $412;
  • Adjusted EBITDA1 was $87 compared to $112, a decrease of $25;
  • Ending cash position was $13,944…



Click here to view the original article.

Related Posts

You might also like ...

AON Splash Image
Arkema annonce le lancement d’une nouvelle gamme innovante de grades PVDF d’origine renouvelable pour les batteries lithium-ion
Le Family Office Alpha Blue Ocean annonce la nomination de Rajae Elantari au poste de Responsable Marketing et Relations Exterieurs
Ferrari Selects AWS as its Official Cloud Provider to Power Innovation on the Road and Track